Shylet Chengedza, Ph.D.
Affiliations: | 2009 | University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States |
Area:
Biochemistry, Oncology, Cell BiologyGoogle:
"Shylet Chengedza"Parents
Sign in to add mentor| Doris M. Benbrook | grad student | 2009 | University of Oklahoma Health Sciences Center | |
| (Molecular mechanism of apoptosis induction by SHetA2 in ovarian cancer cells.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chengedza S, Benbrook DM. (2010) NF-kappaB is involved in SHetA2 circumvention of TNF-alpha resistance, but not induction of intrinsic apoptosis. Anti-Cancer Drugs. 21: 297-305 |
| Moxley KM, Chengedza S, Benbrook DM. (2010) Erratum to “Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents” [Gynecol. Oncol. 115 (2009) 438–442] Gynecologic Oncology. 117: 510 |
| Moxley KM, Chengedza S, Benbrook DM. (2009) Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents. Gynecologic Oncology. 115: 438-42 |
| Liu T, Masamha CP, Chengedza S, et al. (2009) Development of flexible-heteroarotinoids for kidney cancer. Molecular Cancer Therapeutics. 8: 1227-38 |
| Myers T, Chengedza S, Lightfoot S, et al. (2009) Flexible heteroarotinoid (Flex-Het) SHetA2 inhibits angiogenesis in vitro and in vivo. Investigational New Drugs. 27: 304-18 |
| Benbrook DM, Lightfoot S, Ranger-Moore J, et al. (2008) Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention. Gene Regulation and Systems Biology. 2: 21-42 |